A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
Clinical trial NCT04849728 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04849728
- Sponsor
- Inventiva Pharma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-19
- Primary completion
- 2027-09-30
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.